Crinetics Pharmaceuticals Total Liabilities 2017-2024 | CRNX

Crinetics Pharmaceuticals total liabilities for the quarter ending September 30, 2024 were $0.104B, a 11.31% increase year-over-year.

  • Crinetics Pharmaceuticals total liabilities for 2023 were $0.096B, a 168.49% increase from 2022.
  • Crinetics Pharmaceuticals total liabilities for 2022 were $0.036B, a 87.97% increase from 2021.
  • Crinetics Pharmaceuticals total liabilities for 2021 were $0.019B, a 31.29% increase from 2020.

Crinetics Pharmaceuticals Total Liabilities 2017-2024 | CRNX

  • Crinetics Pharmaceuticals total liabilities for 2023 were $0.096B, a 168.49% increase from 2022.
  • Crinetics Pharmaceuticals total liabilities for 2022 were $0.036B, a 87.97% increase from 2021.
  • Crinetics Pharmaceuticals total liabilities for 2021 were $0.019B, a 31.29% increase from 2020.